
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in pat... Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 2.11 | 2.11 | 2.11 | 0 | 0 | CS |
4 | 0 | 0 | 2.11 | 2.11 | 2.11 | 0 | 0 | CS |
12 | -0.14 | -6.22222222222 | 2.25 | 2.4 | 1.69 | 41656 | 2.11769529 | CS |
26 | -0.62 | -22.7106227106 | 2.73 | 4.4 | 1.69 | 67268 | 2.87501998 | CS |
52 | -3.79 | -64.2372881356 | 5.9 | 7.42 | 1.61 | 73833 | 3.43892834 | CS |
156 | -5.89 | -73.625 | 8 | 15 | 1.01 | 203277 | 5.05004527 | CS |
260 | -7.988 | -79.1047732224 | 10.098 | 49.4 | 1.01 | 585750 | 23.40263632 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions